Yohimbine derivatives and use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 30, 2008
Grant Date -
N/A
app pub date -
Aug 23, 2005
filing date -
Aug 23, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Yohimbine derivatives are disclosed having modification of the C-16 carboxyl group to include a sidechain and where the resulting derivative does not possess a second yohimbine pharmacophore (i.e., the compound is not a yohimbine dimer). The yohimbine derivatives of the present invention are preferably characterized by selective activity as .alpha..sub.2c-AR antagonists. Use of the compounds, or pharmaceutical composition containing them, for treating or preventing an .alpha..sub.2c adrenergic receptor mediated condition or disorder, and for antagonizing activity of an .alpha..sub.2c adrenergic receptor are also disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully